HU201685B - For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition - Google Patents

For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition

Info

Publication number
HU201685B
HU201685B HU871747A HU174787A HU201685B HU 201685 B HU201685 B HU 201685B HU 871747 A HU871747 A HU 871747A HU 174787 A HU174787 A HU 174787A HU 201685 B HU201685 B HU 201685B
Authority
HU
Hungary
Prior art keywords
scenting
air
compositions
inhalation
active component
Prior art date
Application number
HU871747A
Other languages
Hungarian (hu)
Other versions
HUT46343A (en
Inventor
Erich Horvath
Jozsef Szejtli
Lajos Szente
Halina Magisztrak
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Priority to HU871747A priority Critical patent/HU201685B/en
Priority to PCT/HU1988/000025 priority patent/WO1988008304A1/en
Publication of HUT46343A publication Critical patent/HUT46343A/en
Publication of HU201685B publication Critical patent/HU201685B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/042—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating with the help of a macromolecular compound as a carrier or diluent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU871747A 1987-04-23 1987-04-23 For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition HU201685B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU871747A HU201685B (en) 1987-04-23 1987-04-23 For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition
PCT/HU1988/000025 WO1988008304A1 (en) 1987-04-23 1988-04-22 Pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU871747A HU201685B (en) 1987-04-23 1987-04-23 For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition

Publications (2)

Publication Number Publication Date
HUT46343A HUT46343A (en) 1988-10-28
HU201685B true HU201685B (en) 1990-12-28

Family

ID=10955988

Family Applications (1)

Application Number Title Priority Date Filing Date
HU871747A HU201685B (en) 1987-04-23 1987-04-23 For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition

Country Status (2)

Country Link
HU (1) HU201685B (en)
WO (1) WO1988008304A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02279629A (en) * 1989-04-18 1990-11-15 Remon Glass Food Kk Antitumor agent adaptive to pulmonary carcinoma
CA2017156A1 (en) * 1989-06-02 1990-12-02 Sotoo Asakura Preparation of fr115224 substance for parenteral administration
FR2666227A1 (en) * 1990-09-05 1992-03-06 Darcy Laboratoires Therapeutic composition, in particular for the treatment of complaints of the buccal cavity
ES2099428T3 (en) * 1992-03-10 1997-05-16 Fisons Plc PHARMACEUTICAL COMPOSITIONS FOR INHALATION.
US5653971A (en) * 1995-06-30 1997-08-05 The Gillette Company Shaving aid composite with an inclusion complex of a skin-soothing agent and a cyclodextrin
FR2815540B1 (en) † 2000-10-19 2005-06-10 Separex Sa PROCESS FOR MANUFACTURING VERY FINE PARTICLES COMPRISING A PRINCIPLE INSERTED IN A HOST MOLECULE
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20030118512A1 (en) * 2001-10-30 2003-06-26 Shen William W. Volatilization of a drug from an inclusion complex
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
CA2526475A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
ES2594867T3 (en) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US10335378B2 (en) 2013-03-15 2019-07-02 Altria Client Services Llc Inhibition of central nervous system effects from smoking and sensory effects from smoking

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB679573A (en) * 1950-01-11 1952-09-17 Mentholatum Company Ltd Improvements in or relating to medicative inhalants
JPS5423966B2 (en) * 1972-11-11 1979-08-17
GB1515630A (en) * 1975-11-24 1978-06-28 Johnson & Son Inc S C Air freshener gels based on amylose
EP0013688B1 (en) * 1978-12-15 1984-02-01 Kyoshin Co., Ltd. A perfumed synthetic resin product and a method of producing said product
US4247535A (en) * 1979-11-05 1981-01-27 American Cyanamid Company Modified cyclodextrin sulfate salts as complement inhibitors
AU558787B2 (en) * 1981-01-23 1987-02-12 Wellcome Foundation Limited, The Inclusion complexes of cyclodextrins and cardiac clycosides
HU196306B (en) * 1985-04-01 1988-11-28 Chinoin Gyogyszer Es Vegyeszet New dusting powders comprising bioactive material and process for preparing the same
JPH0637388B2 (en) * 1986-02-17 1994-05-18 千寿製薬株式会社 Aqueous solution

Also Published As

Publication number Publication date
WO1988008304A1 (en) 1988-11-03
HUT46343A (en) 1988-10-28

Similar Documents

Publication Publication Date Title
PL316199A1 (en) Methods of and compositions for administering insulin into lungs
IL98025A0 (en) 1,3-oxathiolane nucleoside analogues,methods for the preparation thereof and pharmaceutical compositions containing the same
IL89167A0 (en) Substituted pyrroles,their manufacture and pharmaceutical compositions containing them
IL91952A0 (en) Piperidinyl benzimidazoles,their preparation and pharmaceutical compositions containing them
SG107591G (en) Foamed air freshener composition
IL92377A0 (en) Quinuclidines,their preparation and pharmaceutical compositions comprising them
ZA884425B (en) Reduced base-content chewing gum compositions having anesthetic properties
HU900221D0 (en) Fungicid composition comprising acyl-amino-benzamides as active ingredient and process for preparation thereof
HU201685B (en) For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition
IL92580A (en) Aryl-substituted cyclic ether derivatives, their preparation and pharmaceutical compositions containnig them
JPS6426578A (en) 2,2-dimethylchroman-3-ol derivative, manufacture and drug composition
NZ235222A (en) Inhalatory composition comprising salmeterol and beclomethasone dipropionate
IL99074A0 (en) 3-substituted piperidines,process for their preparation and pharmaceutical compositions containing them
HK1023508A1 (en) Stabilized tibolone compositions.
IL116190A (en) Eleutherobin, analogs thereof and pharmaceutical compositions containing them
IL90315A0 (en) Imidazoquinoxaline compounds,their preparation and pharmaceutical compositions containing them
IL88002A0 (en) 2,2-dimethylchromene derivatives,their preparation and pharmaceutical compositions containing them
IL93317A0 (en) Cell antiproliferation factor containing suppressin,processes for the preparation thereof and pharmaceutical compositions containing the same
PH21673A (en) Solid drug formulations and stable suspensions
IL91675A0 (en) Cyclic compounds,pharmaceutical compositions containing the same and processes for the preparation thereof
ZA894857B (en) Oral anaesthetic composition
JPS6422863A (en) Aminocyclopentyl ether, manufacture and medicinal composition
PH23436A (en) 1,4-dihydropyridine derivatives,in optically active or racemate form and their pharmaceutical compositions
IL87016A0 (en) Phenylpiperidine derivatives,their preparation and pharmaceutical compositions containing them
IL90231A0 (en) 1,1-dioxo-cephem-4-carbothiolic acid derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee